Height and Weight



Keith has a normal BMI yet still developed type 2 diabetes. Twenty percent of adults with diabetes are not overweight or obese.
It is clear that obesity increases the risk of developing type 2 diabetes. A large U.S. study has found that of the adults with diabetes, 80% were overweight, and 49% were obese. While the dataset used in this study does not distinguish between type 1 and type 2, other studies have also found clear associations between overweight/obesity and type 2 diabetes. It is interesting to note, however, that 20% of the people with diabetes in this study were not overweight (Nguyen et al. 2010).
 
Some researchers propose that increased weight gain is also responsible for the increased incidence of type 1 diabetes (see "The Accelerator Hypothesis" on the hypotheses page; Wilkin 2001; Wilkin 2008). On the other hand, taller height has long been recognized as associated with type 1 diabetes; in the 1920s, Dr. Elliot Joslin, a pioneer in diabetes treatment said, "overheight was more frequent a precursor of diabetes in children than was overweight in adults" (quoted in Gale 2005b).
 
A number of studies have found evidence that a higher body mass index (BMI), and sometimes increased height or weight gain, may affect the development of type 1 diabetes. For example:
  • A study from five European countries found that rapid growth in early childhood by height, weight, or BMI increases the risk of type 1 diabetes (EURODIAB Substudy 2 Study Group 2002).
  • An analysis of data from multiple studies found that high birth weight and increased weight gain during the first year of life were associated with an increased risk of type 1 diabetes (Harder et al. 2009).
  • A study of Finnish children found that increased height, weight, and BMI were associated with increased incidence of type 1 diabetes (Knip et al. 2008).
  • A study of Swedish children found that rapid growth before age 7 and increased BMI increased the risk of developing type 1 diabetes (Ljungkrantz et al. 2008).
  • In a large study of German and Austrian children, a higher BMI was associated with a younger age of type 1 diabetes onset (Knerr et al. 2005).
  • A six-center U.S. study found increased BMI was associated with a younger age of type 1 diabetes diagnosis only among children with reduced beta cell function (Dabelea et al. 2006).
  • A U.S. study from Washington State found an increased risk of type 1 diabetes in children of mothers with a high BMI (D'Angeli et al. 2010), although other studies have not confirmed this finding (Robertson and Harrild 2010).
  • And, a meta-analysis that incorporated data from 9 separate studies found overall evidence for an association between increased BMI and increased risk for subsequent type 1 diabetes (Verbeeten et al. 2011).
It is important to note that even moderately increased growth rates, not necessarily to the level of obesity, appears to be associated with an increased risk of type 1 diabetes (Dahlquist 2006).
 
Some studies, however, have found that an increased BMI cannot explain the increased incidence of type 1 diabetes in their study areas (e.g., Svensson et al. 2007 and O'Connell et al. 2007).
 
In a prospective study from Australia that followed people over time, weight gain (but not taller height) early in life has been found to increase the risk of type 1 diabetes-related autoimmunity in children who have an increased genetic risk of type 1 diabetes (Couper et al. 2009). On the other hand, in a U.S. prospective study of genetically at-risk children, taller height was found to increase the risk of autoimmunity and type 1 diabetes. Weight gain, however, did not show an increased risk (Lamb et al. 2009). These authors suggest that the differences in their findings may be due to the different ages of the children, or because of differing genetic risk.
 
A large, multiethnic U.S. study looked at children who already had diabetes, in relation to BMI. It found that the large majority of children with type 2 diabetes (79%) were obese, and another 10% were overweight. In comparison, 13% of the children with type 1 diabetes were obese, and 22% overweight. Among U.S. youth without diabetes, 17% were obese, and 16% overweight. So, the obesity rate was lower among children with type 1 than the general population, although the opposite held for those overweight (Liu et al. 2010).
 
Interestingly, obesity is sometimes associated with vitamin D deficiency, probably because vitamin D can be deposited in fat stores which decreases availability to the rest of the body (Holick 2004). Vitamin D appears to be protective against the development of type 1 diabetes (see the vitamin D page). 
 
In his Accelerator Hypothesis, Wilkin (2001) proposes that weight gain causes an increase in insulin resistance. Beta cells stressed by insulin resistance are more of a target to the immune system, and insulin resistance thus accelerates beta cell death and the appearance of type 1 diabetes. Weight gain and physical inactivity, Wilkin proposes, account for the rising incidence in both type 1 and type 2 diabetes in developed countries.
 
In the opinion of Gale (2007), the editor of the journal Diabetologia, "Children destined to develop type 1 diabetes grow faster and fatter in early life, but this could be a consequence rather than a cause of their predisposition to diabetes. Childhood obesity may have contributed to the linear rise of childhood type 1 diabetes over the past 50 years, but does not explain it."

Looking at weight gain and diabetes without considering the role of environmental contaminants may not be sufficient. A provocative study found that people who were obese did not have an increased prevalence of diabetes if they also had very low concentrations of persistent organic pollutants (POPs). Only in people with certain POP levels was obesity associated with diabetes. On the other hand, the associations between POPs and diabetes were stronger in obese individuals than in people who were lean, implying that obesity may increase the toxicity of the POPs. This study found striking associations between POPs and diabetes, and is discussed further on the POP page. The dataset it used did not distinguish between type 1 and type 2 diabetes, although most participants probably had type 2 (Lee et al. 2006). There have not yet been any other studies large enough to further examine this finding, although it certainly merits further research.

Environmental contaminants and weight: Obesogens

In 2002, Baillie-Hamilton (2002) proposed the hypothesis that environmental contaminants could help to explain the modern obesity epidemic. She pointed out that numerous widely-used chemicals could actually produce weight gain in animals, including a number of POPs, pesticides, organophosphates, heavy metals, solvents, phthalates, and bisphenol A. Subsequent research has largely supported this hypothesis, and identified additional contaminants that can promote weight gain. When female mice are exposed to a low dose of the endocrine (hormone) disrupting drug diethylstilbestrol (DES) in the first five days of life, they gain more weight by six months of age than mice who are not exposed (Newbold et al. 2009). Can other endocrine (hormone) disrupting compounds have a similar effect in humans?

The term "obesogen," coined by Drs. Grun and Blumberg, is now used to refer to chemicals than promote weight gain. The Collaborative on Health and the Environment provides a fact sheet on obesogens. Environmental Health Perspectives also has an informative article, Obesogens: An Environmental Link to Obesity (Holtcamp 2102).

A study has shown experimentally that exposure to a mixture of persistent organic pollutants (POPs), taken from farmed Atlantic salmon, can lead to obesity (and insulin resistance) in rats. Of these POPs, the organochlorine pesticides and DDT inhibited insulin action in the fat cells themselves, and affected gene expression. Some types of PCBs also reduced insulin action in the fat cells, but not as strongly (Ruzzin et al. 2010). Exposure to the POP tributyltin has also been found to increase weight gain in animals (Grün et al. 2006).

Rubin et al. (2001) found that mother rats exposed to low doses of bisphenol A had heavier offspring, even after the exposure ended. The weight gain persisted longer in females, and, interestingly, was higher at lower doses. Exposure to bisphenol A in utero and in early life can not only affect the body weight of animals, but affect fat cells as well (Rubin and Soto 2009).

In humans, Verhulst et al. (2009) found that prenatal exposure to the POPs DDE and PCBs is associated with increased BMI during the first three years of life. Smink et al. (2008) found that in utero exposure to higher levels of the POP hexachlorobenzene (HCB) was associated with a higher BMI at age 6 (but not taller height). A study by Karmaus et al. (2009) found that in utero exposure to DDE, but not to PCBs, is associated with increased weight and BMI in adult women. Mendez et al. (2010) found that in utero exposure to the POP DDE was associated with more rapid growth in the first 6 months of life, and higher BMI at 14 months of age, in children of normal weight mothers. Valvi et al. (2011) found that in utero levels of PCBs and DDT were associated with weight changes at age 6.5, in children with moderate exposure levels. In older adults, POPs have been associated with abdominal obesity in Sweden (Lee et al. 2012). A further study found that girls exposed to higher levels of PFOA in the womb, were more likely to be overweight or obese at age 20 (PFOA is a chemical used in the manufacturing of teflon) (Halldorsson et al. 2012).  
 
Levels of several phthalate metabolites have been associated with abdominal obesity and insulin resistance in U.S. men (Stahlhut et al. 2007). In another U.S. study of people aged 6-80, various phthalate metabolites were associated with body mass index (BMI) and waist circumference, although results varied by age and gender (Hatch et al. 2008). For more studies on this topic, see the pages on specific environmental contaminants.

Curiously, some overweight elderly people seem to have a lower risk of death than those who are thin. Some researchers propose that the extra fat tissue provides a relatively safe place to store toxic chemicals (many persistent chemicals bind to fat molecules), as compared to storing the chemicals in more critical organs. They have found that in people with low levels of POPs, excess fat did contribute to increased mortality, as we'd expect. In people with higher levels, however, excess fat was protective. Weight loss in the elderly may be dangerous for those with higher POP levels (Hong et al. 2011).
 
A number of review articles summarize recent findings on endocrine disrupting compounds and obesity, including:

The May 25, 2009 issue of the journal Molecular and Cellular Endocrinology published a special issue on the role of environmental endocrine disrupting contaminants in the development of obesity and diabetes. A number of articles may be of interest here:

  • Nadal et al. (2009) write about the pancreatic beta cells as a target of estrogen and estrogenic compounds. They discuss how estrogenic compounds such as bisphenol A can increase insulin resistance as well as increase insulin secretion, overstimulating beta cells, and thereby contribute to the development of type 2 diabetes.
  • Heindel and vom Saal (2009) propose a hypothesis that the recent increase in obesity is due to both nutrition and environmental contaminant exposures in early life.
  • Grün and Blumberg (2009) review the evidence that a variety of endocrine disrupting contaminants can influence fat formation and obesity, and find that these compounds can interfere with the body's weight control mechanisms.
  • Newbold et al. (2009) review the mechanisms involved in endocrine disruption and obesity, and present evidence supporting the "developmental origins of adult disease" hypothesis.
  • Rubin and Soto (2009) discuss early life and in utero exposure to bisphenol A and how these exposures may affect body weight.
  • Ben-Jonathan et al. (2009) review the ability of low-level bisphenol A exposure to stimulate the release of inflammatory substances from fat cells as well as suppress the hormone adiponectin (which could increase insulin resistance), and discuss the implications of these findings for obesity-related diseases.
  • Desvergne et al. (2009) discuss how phthalates may contribute to the development of obesity.
  • Hines et al. (2009) found that in utero exposure to low doses of perfluorooctanoic acid (PFOA) led to increased body weight in mice in mid-life. PFOA is used in various consumer products (e.g., food wrappers, clothing, non-stick pans), persists in the environment, and is found in the bodies of people in the general U.S. population.
  • Schwitzgebel et al. (2009) discuss how intrauterine growth retardation (IUGR) can decrease beta cell mass in rodents (IUGR means poor fetal growth, and is associated with the development of type 2 diabetes and obesity, but not type 1. Type 1 diabetes is associated with high birth weight; see the gestation and birth page).
  • Gabory et al. (2009) review how gene expression can be affected throughout life (and sometimes in subsequent generations) by factors such as environmental contaminants and nutrition, with a focus on gender variations.

Environmental contaminants and height

The effects that environmental contaminants can have on other growth rates, such as height, are less consistent. In humans, prenatal exposure to DDE has been associated with increased height and weight in boys at puberty (Gladen et al. 2000). The effects of contaminants appear to depend on gender, as well as the type of contaminant. PCBs, for example, have usually been associated with lower growth rates in animals and humans, but sometimes various PCB types have been associated with increased height in boys (Lamb et al. 2006) or girls (Hertz-Picciotto et al. 2005).

The bottom line

Environmental contaminant exposures may contribute to increased weight gain, especially if exposure occurs during development. Increased weight gain is associated with type 2 diabetes. But, weight gain may also be able to accelerate the appearance of type 1 diabetes and may contribute to the increasing incidence of type 1 diabetes, as well as type 2.  The possibility that weight gain can increase the risk of type 2 diabetes only in people exposed to certain levels of contaminants deserves further study.

Links

The RSS Feed of new articles on diabetes and chemicals is provided courtesy of Health & Environment

 
 
 

Contact

For comments, questions, or suggestions, email sarah@